Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
05 2021
Historique:
received: 26 01 2021
revised: 19 02 2021
accepted: 22 02 2021
pubmed: 6 3 2021
medline: 16 10 2021
entrez: 5 3 2021
Statut: ppublish

Résumé

Encapsulated papillary carcinomas (EPCs) of the breast are a unique variant of papillary carcinoma confined to a cystic space with absent or attenuated myoepithelial cell layer. Although staged as an in situ lesion, it can be associated with invasive ductal carcinoma (IDC). We sought to compare the genomic characteristics of pure EPC and EPC with associated invasive carcinoma (EPCi) at the genomic level. All cases of EPCi harbored recurrent hotspot mutations in PIK3CA. PIK3CA, KMT2A, and CREBBP deleterious somatic events were found across both tumor groups, irrespective of invasion status. At the whole transcriptomic level, EPCi cases displayed remarkably similar mRNA profiles when compared to EPC. When EPCi cases were compared with their corresponding IDC, despite significant overlap, we identified differential gene expression in 39 genes with enrichment of multiple pathways including extracellular matrix regulation, cell adhesion, and collagen fibril organization. Despite morphologic, genotypic, and transcriptomic overlap between pure EPC and EPCi, the latter tumors are likely advanced lesions with PIK3CA activating mutations and enrichment of stromal-related genes implicated in the switch to IDC.

Identifiants

pubmed: 33667422
pii: S0046-8177(21)00030-7
doi: 10.1016/j.humpath.2021.02.005
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
PIK3CA protein, human EC 2.7.1.137

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-74

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Christopher J Schwartz (CJ)

New York University Medical Center, New York, NY, 10016, USA.

Amir Momeni Boroujeni (AM)

Brigham and Women's Hospital, Boston, MA, 02115, USA.

Alireza Khodadadi-Jamayran (A)

New York University Medical Center, New York, NY, 10016, USA.

Adriana Heguy (A)

New York University Medical Center, New York, NY, 10016, USA.

Matija Snuderl (M)

New York University Medical Center, New York, NY, 10016, USA.

George Jour (G)

New York University Medical Center, New York, NY, 10016, USA.

Paolo Cotzia (P)

New York University Medical Center, New York, NY, 10016, USA.

Farbod Darvishian (F)

New York University Medical Center, New York, NY, 10016, USA. Electronic address: Farbod.darvishian@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH